Profile

VeriLuce Therapeutics is a discovery/early-stage drug company in the process of developing small molecules to act as immuno-modulators in the tumor micro-environment with the objective to slow down/stop tumor growth and metastasis. In particular, VeriLuce is developing small molecules to act as dual antagonists against two specific chemokine receptors.

VeriLuce Therapeutics Logo

Website

www.verilucetherapeutics.com

Contact


Event details

Date: June 10 - 17, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

30 in total